Novel mutations in breast cancer patients from Southwestern Colombia

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Breast cancer is the leading cause of death by cancer among women in less developed regions. In Colombia, few pub-lished studies have applied next-generation sequencing technologies to evaluate the genetic factors related to breast cancer. This study characterized the exome of three patients with breast cancer from southwestern Colombia to identify likely pathogenic or disease-related DNA sequence variants in tumor cells. For this, the exomes of three tumor tissue samples from patients with breast cancer were sequenced. The bioinformatics analysis identified two pathogenic variants in Fgfr4 and Nf1 genes, which are highly relevant for this type of cancer. Specifically, variant FGFR4-c.1162G>A predisposes individuals to a significantly accelerated progression of this pathology, while NF1-c.1915C>T negatively alters the encoded protein and should be further investigated to clarify the role of this variant in this neoplasia. More-over, 27 novel likely pathogenic variants were found and 10 genes showed alterations of pathological interest. These results suggest that the novel variants reported here should be further studied to elucidate their role in breast cancer.

Cite

CITATION STYLE

APA

Solarte, M., Cortes-Urrea, C., Franco, N. R., Barreto, G., & Moreno, P. A. (2020). Novel mutations in breast cancer patients from Southwestern Colombia. Genetics and Molecular Biology, 43(4), 1–5. https://doi.org/10.1590/1678-4685-GMB-2019-0359

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free